Eyeworld Supplements

EW OCT 2020 - Supported by Allergan, Kala Pharmaceuticals, Novartis, and Sight Sciences. As well as Eyevance and Johnson & Johnson Vision

This is a supplement to EyeWorld Magazine.

Issue link: https://supplements.eyeworld.org/i/1288622

Contents of this Issue

Navigation

Page 8 of 11

OCTOBER 2020 | SUPPLEMENT TO EYEWORLD | 9 Platinum sponsors: Allergan, Kala Pharmaceuticals, Novartis, and Sight Sciences Bronze sponsors: Eyevance and Johnson & Johnson Vision Reversing a toric decision One patient Dr. Beckman saw for a toric evaluation had 3 D of irregular astigmatism. Looking at the location of the astigmatism and the mires on Placido imaging, Dr. Beckman knew something else was afoot. "When I did my dry eye workup, I noted he had a rapid tear breakup time, staining, lid margins were a mess," he said. After 2 weeks treating the dry eye, the patient's vision was so much better that he didn't need a toric IOL. His astigmatism was actually 0.5 D. Though this was before the algorithm was developed, Dr. Beckman said it highlights the importance of knowing what you're treating and eliminating other factors before you jump into cataract surgery. Topography and Placido imaging indicated 3 D of irregular astigmatism. The patient, however, didn't have corneal astigmatism that merited a toric IOL, rather dry eye and blepharitis. Once OSD was addressed, the irregular astigmatism decreased and mires became regular. Source: Kenneth Beckman, MD Keratoconus? Though not a cataract surgery evaluation, Dr. Beckman also described a patient he saw for keratoconus and crosslinking consultation. He observed irregular cones on topography and determined it was due to the tear film. After treating the dry eye, the topography normalized and the patient didn't even have keratoconus. "This is a great example of how the tear film may affect corneal measurements for any surgery and needs to be optimized before moving forward," he said. Top: A patient referred for keratoconus evaluation showed irregular topographies of the right and left eye. Bottom: The patient was diagnosed with severe dry eye, which after treatment resolved and revealed the patient did not have keratoconus. Source: Kenneth Beckman, MD

Articles in this issue

Archives of this issue

view archives of Eyeworld Supplements - EW OCT 2020 - Supported by Allergan, Kala Pharmaceuticals, Novartis, and Sight Sciences. As well as Eyevance and Johnson & Johnson Vision